ConductScience.org, home

Paper41276264

Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV-related disease and harms from vaccination.

Henschke N and 11 others. Cochrane Database Syst Rev, 2025. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV-related disease and harms from vaccination. Papers, record 41276264. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41276264

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV-related disease and harms from vaccination.
PubMed
Journal
Cochrane Database Syst Rev
PubMed
Year
2025
PubMed
Publication types
Journal Article, Systematic Review, Meta-Analysis
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
5.01, provisional
iCite
Revised in PubMed
2026-09-26
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Henschke NNicholashttps://orcid.org/0000-0002-9624-2519
2Bergman HHanna
3Buckley BSBrian S
4Crosbie EJEmma J
5Dwan KKerry
6Golder SPSu P
7Kyrgiou MMaria
8Loke YKYoon Kong
9McIntosh HMHeather M
10Probyn KKatrin
11Villanueva GGemma
12Morrison JJo

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Papillomavirus VaccinesMajor topic
Uterine Cervical NeoplasmsMajor topic
Papillomavirus InfectionsMajor topic
VaccinationMajor topic
Humans
Female
Adolescent
Bias
Randomized Controlled Trials as Topic
Male
Adult
Human Papillomavirus Viruses

Source PubMed

Download CSV of topics

References532

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135335051Real-Life Safety Profile of the 9-Valent HPV Vaccine Based on Data from the Puglia Region of Southern Italy.Vaccines (Basel)2022https://conductscience.org/library/papers/35335051PubMed
225944340Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550,000 Young Girls.Clin Infect Dis2015https://conductscience.org/library/papers/25944340PubMed
336418848Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting.Curr Pain Headache Rep2022https://conductscience.org/library/papers/36418848PubMed
432091594Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial.J Natl Cancer Inst2020https://conductscience.org/library/papers/32091594PubMed
526967300Significant Reduction in the Incidence of Genital Warts in Young Men 5 Years into the Danish Human Papillomavirus Vaccination Program for Girls and Women.Sex Transm Dis2016https://conductscience.org/library/papers/26967300PubMed
638890675The prevalence and genotype distribution of high-risk human papillomaviruses among women in Xianning, China.Virol J2024https://conductscience.org/library/papers/38890675PubMed
730980966Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006-2014: The impact of human papillomavirus vaccination.Papillomavirus Res2019https://conductscience.org/library/papers/30980966PubMed
832483924Geographical disparities in human papillomavirus herd protection.Cancer Med2020https://conductscience.org/library/papers/32483924PubMed
934590059Genital warts trends in Australian and overseas-born people in Australia: A cross-sectional trend analysis to measure progress towards control and elimination.Lancet Reg Health West Pac2021https://conductscience.org/library/papers/34590059PubMed
1030944092Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study.BMJ2019https://conductscience.org/library/papers/30944092PubMed
1129523448Substantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in Sweden.Vaccine2018https://conductscience.org/library/papers/29523448PubMed
1238314927Effectiveness of prophylactic HPV vaccines against cervical abnormalities and HPV infection in Japan: The J-HERS 2021 multicenter study.J Med Virol2024https://conductscience.org/library/papers/38314927PubMed
1325324358Graphical presentation of confounding in directed acyclic graphs.Nephrol Dial Transplant2015https://conductscience.org/library/papers/25324358PubMed
1434980629Incidence and clearance of oral and cervicogenital HPV infection: longitudinal analysis of the MHOC cohort study.BMJ Open2022https://conductscience.org/library/papers/34980629PubMed
1530249423Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions.Vaccine2018https://conductscience.org/library/papers/30249423PubMed
1638433222Vaccination and the risk of systemic lupus erythematosus: a meta-analysis of observational studies.Arthritis Res Ther2024https://conductscience.org/library/papers/38433222PubMed
1729432858GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence.J Clin Epidemiol2019https://conductscience.org/library/papers/29432858PubMed
1823804192Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark.Clin Infect Dis2013https://conductscience.org/library/papers/23804192PubMed
1937667847Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and Safety.Pediatrics2023https://conductscience.org/library/papers/37667847PubMed
2035347326The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot.Br J Cancer2022https://conductscience.org/library/papers/35347326PubMed

See all 532 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
42934622Immediate histological risk and one-year outcomes following P16-based triage of HPV-positive women.BMC Womens Health2026https://conductscience.org/library/papers/42934622PubMed
42797652The Future of Vaccines.Vaccines (Basel)2026https://conductscience.org/library/papers/42797652PubMed
42778616From blunt-force treatment to precision: 25 years of transformation in cancer research.Nat Rev Cancer2026https://conductscience.org/library/papers/42778616PubMed
42646704Post-Marketing Safety Surveillance of Autoimmune Diseases Following Bivalent Human Papillomavirus Vaccination in China.Vaccines (Basel)2026https://conductscience.org/library/papers/42646704PubMed
42338536Exploring current cancer screening practices and guidelines for adults under age 50 in the United States.Front Public Health2026https://conductscience.org/library/papers/42338536PubMed
42334459Understanding the roots of hesitancy to unlock the game-changing impact of HPV vaccination: Insights from a global qualitative evidence synthesis.Hum Vaccin Immunother2026https://conductscience.org/library/papers/42334459PubMed
42279168Impact of Body Mass Index on Clinical Outcomes of LLETZ.J Clin Med2026https://conductscience.org/library/papers/42279168PubMed
42254807Association of Guillain-Barré Syndrome With Nonavalent Human Papillomavirus Vaccine: A Postmarketing Drug Safety Study.Obstet Gynecol Int2026https://conductscience.org/library/papers/42254807PubMed
42169564AOGIN India Policy Statement on the Use of HPV Vaccination for Cervical Cancer Elimination.Asian Pac J Cancer Prev2026https://conductscience.org/library/papers/42169564PubMed
41893773A Pocket Manual for Human Papillomavirus Vaccines.Vaccines (Basel)2026https://conductscience.org/library/papers/41893773PubMed
41682676Association Between Human Papillomavirus Vaccination and the Risk of Cervical Cancer and Precancerous Lesions in Israel: A Retrospective Cohort Study.J Clin Med2026https://conductscience.org/library/papers/41682676PubMed
41276263Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV-related diseases: a network meta-analysis.Cochrane Database Syst Rev2025https://conductscience.org/library/papers/41276263PubMed
40943226Comparison of Current Immunotherapy Approaches and Novel Anti-Cancer Vaccine Modalities for Clinical Application.Int J Mol Sci2025https://conductscience.org/library/papers/40943226PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41276264

GET https://conductscience.org/api/papers/v1/41276264/references?page=2